Target intelligence / Profile preview

Retinoschisin (RS1)

Target
RS1
Molecular classification
Cell adhesion protein, Secreted protein
01

Overview

Retinoschisin is a soluble, cell-surface protein crucial for the structural and functional maintenance of the retina. Encoded by the RS1 gene, it is primarily expressed by retinal bipolar cells and photoreceptors. Retinoschisin forms paired octamer rings and mediates cell-to-cell adhesion. Mutations in RS1 cause X-linked juvenile retinoschisis (XLRS), a progressive degenerative disease characterized by the formation of cystic cavities within the retina, separation of retinal layers, and ultimately, vision loss. It maintains retinal architecture by binding to plasma membranes of photoreceptor and bipolar cells, facilitating tight cellular organization in the retina.

Other names
X-linked juvenile retinoschisis protein
02

Biological functions

Cell adhesionMaintenance of retinal structureRegulation of MAP kinase signalingModulation of Na/K-ATPase signalingAnti-apoptotic factor
03

Disease associations

X-linked juvenile retinoschisis (XLRS)
04

Safety considerations

Challenges in gene therapy delivery to the retinaPotential for immune response to gene therapy vectors

Beyond the preview

Go deeper on Retinoschisin (RS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retinoschisin (RS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call